Buy Rimonabant
AddThis Social Bookmark Button
AddThis Feed Button
 

About:
Rimonabant
Acomplia
Side effects
Buy Rimonabant
More:
Long Term Weight Loss
Testimonials
Rimonabant news
Tools:
Ideal weight
Body mass index (BMI)
 

 

 

Rimonabant Acomplia

Side Effects


ACOMPLIA 20 mg has been evaluated for safety in approximately 2,500 patients enrolled in studies that examined the metabolic and weight loss effects in overweight and obese patients and in approximately 3,800 patients in other indications.

In placebo-controlled studies, the discontinuation rate due to adverse reactions was 15.7 % for patients receiving rimonabant. The most common adverse reactions resulting in discontinuation were: nausea, mood alteration with depressive symptoms, depressive disorders, anxiety and dizziness.

Depressive disorders were reported in 3.2% of obese patients, or overweight patients with associated risk factor(s) treated with rimonabant 20 mg. These were usually mild or moderate in severity and resulted in recovery in all cases either after corrective treatment or discontinuation of rimonabant and did not exhibit any differentiating characteristics compared to cases reported in the control groups.

The following table shows all treatment-emergent adverse reactions from four placebo-controlled studies in patients treated for weight loss and related metabolic disorders when these incidences were statistically significantly greater than the corresponding placebo rate (for events greater than or equal to 1 %) or considered clinically relevant (for events fewer than 1 %).

Classification of expected frequencies of undesirable effects:

Very common (More than 10 out of 100); Common (More than 1 in 100 but fewer than 10 in 100); Uncommon (More than 1 in 1,000 but fewer than 1 in 100); Rare (More than 1 in 10,000 but fewer than 1 in 1,000); Very rare (Fewer than 1 in 10,000), Not known (cannot be established from the available data).
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.

System Organ
Class

Very common

Common

 

Uncommon

Rare

Infections and infestations

Upper respiratory tract infection

Gastroenteritis

 

 
 

Psychiatric disorders

 

 

Depressive disorders

Mood alterations with depressive symptoms

Anxiety
Irritability
Nervousness
Sleep disorders
Insomnia
Parasomnias

Panic symptoms

Anger

Dysphoria
Emotional disorder

Hallucinations

Nervous system disorders

 

 

Memory loss
Dizziness
Hypoaesthesia
Sciatica

Lethargy

 

 

Vascular disorders

 

 

Hot flush

 

 
 

Respiratory, thoracic and mediastinal disorders

 

 

 

 

Hiccups

 

Gastrointestinal disorders

Nausea

Diarrhoea
Vomiting

 

 
 

Skin and subcutaneous tissue disorders

 

 

Pruritus
Hyperhidrosis 

Night sweats

 

Musculoskeletal and connective tissue disorders

 

 

Tendonitis
Muscle cramp
Muscle spasms

 

 
 

General disorders

 

 

Asthenia/fatigue
Influenza

 

 
 

Injury, Poisoning and procedural complications

 

 

Fall, Contusion, Joint sprain

 

 

 
 

 

Buy Rimonabant - Generic Acomplia

Brief:

Acomplia is the brand name of a new prescription weight loss drug for dieters, Rimonabant, that has recently (June 28th, 2006) been approved for use by patients in the UK.

Acomplia also reduces the desire for nicotine, but is not yet licensed as an aid to stopping smoking.

Acomplia is licensed within the European Union, but has yet to be approved by the FDA in the US.

Acomplia is manufactured by the pharmaceutical company Sanofi Aventis. Its generic name is Rimonabant.



Watch report about Rimonabant

 

 

eXTReMe Tracker